Resideo Technologies (REZI) director reports 4,312-share stock grant
Rhea-AI Filing Summary
Resideo Technologies director equity grant: Director Andrew C. Teich reported receiving 4,312 shares of Resideo Technologies, Inc. common stock on 01/01/2026. The shares are valued at $35.36 per share and were issued under the 2018 Stock Plan for Non-Employee Directors in lieu of annual cash retainer fees. After this grant, he beneficially owns 344,932.631 shares of common stock on a direct basis. The related stock units are fully vested upon grant and are designed to be settled in a lump sum of common shares after his service as a director ends.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,312 | $35.36 | $152K |
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Resideo Technologies (REZI) report in this Form 4?
Resideo Technologies reported that director Andrew C. Teich received 4,312 shares of common stock on 01/01/2026, issued under the company’s 2018 Stock Plan for Non-Employee Directors.
What is the purpose of the 2018 Stock Plan for Non-Employee Directors at Resideo Technologies (REZI)?
According to the disclosure, the 2018 Stock Plan for Non-Employee Directors allows annual cash retainer fees to be taken as stock units, which are settled in a lump sum of common stock after the director’s service ends, and these units are fully vested upon grant.
Is the reported Resideo Technologies (REZI) equity grant to the director vested?
Yes. The explanation states that the stock units are fully vested upon grant and will be settled by issuing shares of common stock in a lump sum after the director’s service terminates.
Is the Resideo Technologies (REZI) Form 4 filed by one or multiple reporting persons?
The filing indicates that it is a Form filed by one reporting person, reflecting the holdings and transaction of a single director.